These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 11087871)

  • 1. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.
    Zimonjic DB; Pollock JL; Westervelt P; Popescu NC; Ley TJ
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13306-11. PubMed ID: 11087871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
    Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
    Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a bcr-1 isoform of RARalpha-PML does not affect the penetrance of acute promyelocytic leukemia or the acquisition of an interstitial deletion on mouse chromosome 2.
    Walter MJ; Ries RE; Armstrong JR; Park JS; Mardis ER; Ley TJ
    Blood; 2007 Feb; 109(3):1237-40. PubMed ID: 17008533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.
    He LZ; Tribioli C; Rivi R; Peruzzi D; Pelicci PG; Soares V; Cattoretti G; Pandolfi PP
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5302-7. PubMed ID: 9144232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.
    Walter MJ; Park JS; Ries RE; Lau SK; McLellan M; Jaeger S; Wilson RK; Mardis ER; Ley TJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12513-8. PubMed ID: 16113082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression.
    Westervelt P; Lane AA; Pollock JL; Oldfather K; Holt MS; Zimonjic DB; Popescu NC; DiPersio JF; Ley TJ
    Blood; 2003 Sep; 102(5):1857-65. PubMed ID: 12750176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
    Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asynchronous expression of myeloid antigens in leukemic cells in a PML/RARalpha transgenic mouse model.
    Santana BA; Pintão MC; Abreu e Lima RS; Scheucher PS; Santos GA; Garcia AB; Falcão RP; Rego EM
    Braz J Med Biol Res; 2006 May; 39(5):615-20. PubMed ID: 16648899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil elastase cleaves PML-RARalpha and is important for the development of acute promyelocytic leukemia in mice.
    Lane AA; Ley TJ
    Cell; 2003 Oct; 115(3):305-18. PubMed ID: 14636558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia.
    Le Beau MM; Bitts S; Davis EM; Kogan SC
    Blood; 2002 Apr; 99(8):2985-91. PubMed ID: 11929790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia.
    Le Beau MM; Davis EM; Patel B; Phan VT; Sohal J; Kogan SC
    Blood; 2003 Aug; 102(3):1072-4. PubMed ID: 12689927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias.
    Merghoub T; Gurrieri C; Piazza F; Pandolfi PP
    Blood Cells Mol Dis; 2001; 27(1):231-48. PubMed ID: 11358384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia.
    Pollock JL; Westervelt P; Kurichety AK; Pelicci PG; Grisolano JL; Ley TJ
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15103-8. PubMed ID: 10611345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved rapid detection of the PML/RARalpha fusion gene in acute promyelocytic leukemia.
    Diverio D; Riccioni R; Pistilli A; Buffolino S; Avvisati G; Mandelli F; Lo Coco F
    Leukemia; 1996 Jul; 10(7):1214-6. PubMed ID: 8684004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of functional interaction between NuMA-RARalpha and RXRalpha in an in vivo model of acute promyelocytic leukemia.
    Sukhai MA; Thomas M; Xuan Y; Chan LS; Hamadanizadeh SA; Zhang T; Bharadwaj RR; Schuh AC; Wells RA; Kamel-Reid S
    Oncogene; 2008 Aug; 27(34):4666-77. PubMed ID: 18408763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
    Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
    Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction].
    Zhu HH; Liu YR; Qin YZ; Li JL; Chang Y; Wang YZ; Shan FX; Jiang B; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):1-5. PubMed ID: 17490509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia.
    Coltella N; Valsecchi R; Ponente M; Ponzoni M; Bernardi R
    Clin Cancer Res; 2015 Aug; 21(16):3685-94. PubMed ID: 25931453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.